TY - STD TI - Key Statistics for Prostate Cancer Date. Available from: https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html2019. Accessed 3 Jan 2019. UR - https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html2019 ID - ref1 ER - TY - JOUR AU - Bokhorst, L. P. AU - Bangma, C. H. AU - Leenders, G. J. AU - Lous, J. J. AU - Moss, S. M. AU - Schröder, F. H. PY - 2014 DA - 2014// TI - Prostate-specific antigen–based prostate Cancer screening: reduction of prostate cancer mortality after correction for nonattendance and contamination in the Rotterdam section of the European randomized study of screening for prostate Cancer JO - Eur Urol VL - 65 UR - https://doi.org/10.1016/j.eururo.2013.08.005 DO - 10.1016/j.eururo.2013.08.005 ID - Bokhorst2014 ER - TY - JOUR AU - Loeb, S. AU - Carter, H. B. AU - Berndt, S. I. AU - Ricker, W. AU - Schaeffer, E. M. PY - 2011 DA - 2011// TI - Complications after prostate biopsy: data from SEER-Medicare JO - J Urol VL - 186 UR - https://doi.org/10.1016/j.juro.2011.06.057 DO - 10.1016/j.juro.2011.06.057 ID - Loeb2011 ER - TY - JOUR AU - Siddiqui, M. M. AU - Rais-Bahrami, S. AU - Turkbey, B. AU - George, A. K. AU - Rothwax, J. AU - Shakir, N. PY - 2015 DA - 2015// TI - Comparison of MR/ultrasound fusion–guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer JO - JAMA VL - 313 UR - https://doi.org/10.1001/jama.2014.17942 DO - 10.1001/jama.2014.17942 ID - Siddiqui2015 ER - TY - JOUR AU - Liss, M. A. AU - Ehdaie, B. AU - Loeb, S. AU - Meng, M. V. AU - Raman, J. D. AU - Spears, V. PY - 2017 DA - 2017// TI - An update of the American urological association white paper on the prevention and treatment of the more common complications related to prostate biopsy JO - J Urol VL - 198 UR - https://doi.org/10.1016/j.juro.2017.01.103 DO - 10.1016/j.juro.2017.01.103 ID - Liss2017 ER - TY - JOUR AU - Zeng, C. AU - Wen, W. AU - Morgans, A. K. AU - Pao, W. AU - Shu, X. -. O. AU - Zheng, W. PY - 2015 DA - 2015// TI - Disparities by race, age, and sex in the improvement of survival for major cancers: results from the National Cancer Institute surveillance, epidemiology, and end results (SEER) program in the United States, 1990 to 2010 JO - JAMA Oncol VL - 1 UR - https://doi.org/10.1001/jamaoncol.2014.161 DO - 10.1001/jamaoncol.2014.161 ID - Zeng2015 ER - TY - JOUR AU - Moyer, V. A. PY - 2012 DA - 2012// TI - Screening for prostate cancer: US preventive services task force recommendation statement JO - Ann Intern Med VL - 157 UR - https://doi.org/10.7326/0003-4819-157-2-201207170-00459 DO - 10.7326/0003-4819-157-2-201207170-00459 ID - Moyer2012 ER - TY - JOUR AU - Shao, Y. -. H. AU - Demissie, K. AU - Shih, W. AU - Mehta, A. R. AU - Stein, M. N. AU - Roberts, C. B. PY - 2009 DA - 2009// TI - Contemporary risk profile of prostate cancer in the United States JO - J Natl Cancer Inst VL - 101 UR - https://doi.org/10.1093/jnci/djp262 DO - 10.1093/jnci/djp262 ID - Shao2009 ER - TY - JOUR AU - Ankerst, D. P. AU - Straubinger, J. AU - Selig, K. AU - Guerrios, L. AU - Hoedt, A. AU - Hernandez, J. PY - 2018 DA - 2018// TI - A contemporary prostate biopsy risk calculator based on multiple heterogeneous cohorts JO - Eur Urol VL - 74 UR - https://doi.org/10.1016/j.eururo.2018.05.003 DO - 10.1016/j.eururo.2018.05.003 ID - Ankerst2018 ER - TY - JOUR AU - Ankerst, D. P. AU - Hoefler, J. AU - Bock, S. AU - Goodman, P. J. AU - Vickers, A. AU - Hernandez, J. PY - 2014 DA - 2014// TI - Prostate Cancer prevention trial risk calculator 2.0 for the prediction of low-vs high-grade prostate cancer JO - Urology VL - 83 UR - https://doi.org/10.1016/j.urology.2014.02.035 DO - 10.1016/j.urology.2014.02.035 ID - Ankerst2014 ER - TY - JOUR AU - Murphy, A. B. AU - Kelley, B. AU - Nyame, Y. A. AU - Martin, I. K. AU - Smith, D. J. AU - Castaneda, L. PY - 2012 DA - 2012// TI - Predictors of serum vitamin D levels in African American and European American men in Chicago JO - Am J Mens Health VL - 6 UR - https://doi.org/10.1177/1557988312437240 DO - 10.1177/1557988312437240 ID - Murphy2012 ER - TY - JOUR AU - Mohler, J. L. AU - Antonarakis, E. S. AU - Armstrong, A. J. AU - D’Amico, A. V. AU - Davis, B. J. AU - Dorff, T. PY - 2019 DA - 2019// TI - Prostate Cancer, version 2.2019, NCCN clinical practice guidelines in oncology JO - J Natl Compr Cancer Netw VL - 17 UR - https://doi.org/10.6004/jnccn.2019.0023 DO - 10.6004/jnccn.2019.0023 ID - Mohler2019 ER - TY - JOUR AU - Vickers, A. J. AU - Elkin, E. B. PY - 2006 DA - 2006// TI - Decision curve analysis: a novel method for evaluating prediction models JO - J Med Decis Making VL - 26 UR - https://doi.org/10.1177/0272989X06295361 DO - 10.1177/0272989X06295361 ID - Vickers2006 ER - TY - JOUR AU - Chiu, P. K. AU - Alberts, A. R. AU - Venderbos, L. D. AU - Bangma, C. H. AU - Roobol, M. J. PY - 2017 DA - 2017// TI - Additional benefit of using a risk-based selection for prostate biopsy: an analysis of biopsy complications in the Rotterdam section of the European randomized study of screening for prostate Cancer JO - BJU Int VL - 120 UR - https://doi.org/10.1111/bju.13913 DO - 10.1111/bju.13913 ID - Chiu2017 ER - TY - JOUR AU - Mehralivand, S. AU - Shih, J. H. AU - Rais-Bahrami, S. AU - Oto, A. AU - Bednarova, S. AU - Nix, J. W. PY - 2018 DA - 2018// TI - A magnetic resonance imaging–based prediction model for prostate biopsy risk stratification JO - JAMA Oncol VL - 4 UR - https://doi.org/10.1001/jamaoncol.2017.5667 DO - 10.1001/jamaoncol.2017.5667 ID - Mehralivand2018 ER - TY - JOUR AU - Vickers, A. J. AU - Calster, B. AU - Steyerberg, E. W. PY - 2016 DA - 2016// TI - Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests JO - BMJ VL - 352 UR - https://doi.org/10.1136/bmj.i6 DO - 10.1136/bmj.i6 ID - Vickers2016 ER - TY - JOUR AU - Roobol, M. J. AU - Verbeek, J. F. AU - Kwast, T. AU - Kümmerlin, I. P. AU - Kweldam, C. F. AU - Leenders, G. J. PY - 2017 DA - 2017// TI - Improving the Rotterdam European randomized study of screening for prostate Cancer risk calculator for initial prostate biopsy by incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth JO - J Eur Oncol VL - 72 ID - Roobol2017 ER - TY - JOUR AU - Vickers, A. J. PY - 2008 DA - 2008// TI - Decision analysis for the evaluation of diagnostic tests, prediction models and molecular markers JO - Am Stat VL - 62 UR - https://doi.org/10.1198/000313008X370302 DO - 10.1198/000313008X370302 ID - Vickers2008 ER - TY - JOUR AU - Ankerst, D. P. AU - Boeck, A. AU - Freedland, S. J. AU - Thompson, I. M. AU - Cronin, A. M. AU - Roobol, M. J. PY - 2012 DA - 2012// TI - Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the prostate biopsy collaborative group JO - World J Urol VL - 30 UR - https://doi.org/10.1007/s00345-011-0818-5 DO - 10.1007/s00345-011-0818-5 ID - Ankerst2012 ER - TY - JOUR AU - Parekh, D. J. AU - Ankerst, D. P. AU - Higgins, B. A. AU - Hernandez, J. AU - Canby-Hagino, E. AU - Brand, T. PY - 2006 DA - 2006// TI - External validation of the prostate Cancer prevention trial risk calculator in a screened population JO - Urology VL - 68 UR - https://doi.org/10.1016/j.urology.2006.10.022 DO - 10.1016/j.urology.2006.10.022 ID - Parekh2006 ER - TY - JOUR AU - Alberts, A. R. AU - Roobol, M. J. AU - Verbeek, J. F. AU - Schoots, I. G. AU - Chiu, P. K. AU - Osses, D. F. PY - 2019 DA - 2019// TI - Prediction of high-grade prostate cancer following multiparametric magnetic resonance imaging: improving the Rotterdam european randomized study of screening for prostate cancer risk calculators JO - Eur Urol VL - 75 UR - https://doi.org/10.1016/j.eururo.2018.07.031 DO - 10.1016/j.eururo.2018.07.031 ID - Alberts2019 ER - TY - JOUR AU - Kim, S. J. AU - Vickers, A. J. AU - Hu, J. C. PY - 2018 DA - 2018// TI - Challenges in adopting level 1 evidence for multiparametric magnetic resonance imaging as a biomarker for prostate cancer screening JO - JAMA Oncol VL - 4 UR - https://doi.org/10.1001/jamaoncol.2018.4160 DO - 10.1001/jamaoncol.2018.4160 ID - Kim2018 ER - TY - JOUR AU - Liu, W. AU - Patil, D. AU - Howard, D. H. AU - Moore, R. H. AU - Wang, H. AU - Sanda, M. G. PY - 2018 DA - 2018// TI - Adoption of prebiopsy magnetic resonance imaging for men undergoing prostate biopsy in the United States JO - Urology VL - 117 UR - https://doi.org/10.1016/j.urology.2018.04.007 DO - 10.1016/j.urology.2018.04.007 ID - Liu2018 ER - TY - JOUR AU - Hansen, N. L. AU - Koo, B. C. AU - Gallagher, F. A. AU - Warren, A. Y. AU - Doble, A. AU - Gnanapragasam, V. PY - 2017 DA - 2017// TI - Comparison of initial and tertiary Centre second opinion reads of multiparametric magnetic resonance imaging of the prostate prior to repeat biopsy JO - Eur Radiol VL - 27 UR - https://doi.org/10.1007/s00330-016-4635-5 DO - 10.1007/s00330-016-4635-5 ID - Hansen2017 ER - TY - JOUR AU - Epstein, J. I. AU - Egevad, L. AU - Amin, M. B. AU - Delahunt, B. AU - Srigley, J. R. AU - Humphrey, P. A. PY - 2016 DA - 2016// TI - The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma JO - Am J Surg Pathol VL - 40 ID - Epstein2016 ER - TY - STD TI - Prostate Cancer Prevention Trial Risk Calculator Version 2.0. Available from: http://riskcalc.org/PCPTRC/. UR - http://riskcalc.org/PCPTRC/ ID - ref26 ER -